Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...
A Memphis woman won’t be making any more trips to Walmart in the foreseeable future. According to a report from WREG, Ashley ...
Trump is amping up tariffs against almost every other country. The Mississippi economy relies on trade with Canada, Mexico, ...
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
Ladies and gentlemen, greetings and welcome to the Pagaya Technologies fourth quarter and full year 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being ...
Good day, everyone, and welcome to the Moody's Corporation fourth quarter and full-year 2024 earnings call. At this time, I would like to inform you that this conference is being recorded. (Operator ...
Baird raised the firm’s price target on Blueprint Medicines (BPMC) to $135 from $127 and keeps an Outperform rating on the shares. The firm ...
Donald Trump's threat to hit trading partners with ‘reciprocal’ tariffs could hit Australian jobs and economic output hard if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results